-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
It is reported that cerebral amyloid vascular disease (CAA) in patients with subcortical calcification, despite its prevalence and pathophysiological mechanisms are not yet clear.
Blood vessel
Recently, a research article was published in Stroke, an authoritative journal in the field of medsci.
medsci.
The researchers included D-CAA mutation carriers with confirmed APP (amyloid precursor protein) mutations or ≥1 lobe ICH.
Researchers found cortical calcification in 15/81 (19% [95% CI 11-29]) D-CAA mutation carriers (15/69 with symptoms and 0/12 pre-symptoms) and 1/59 (2% [95% CI 0-9]) patients with sporadic CAA.
It can be seen that calcification of the occipital cortex is very common in D-CAA, but it is rare in sporadic CAA.
Occipital cortex calcification is common in D-CAA, but it is rare in sporadic CAA.
Original source:
Ingeborg Rasing.
